article_metadata: Tsukasa Yoshida Hiroshi Yaegashi Ren Toriumi Suguru Kadomoto Hiroaki Iwamoto Kouji Izumi Yoshifumi Kadono Hiroko Ikeda Atsushi Mizokami
article_metadata: 10.3389/fonc.2022.912490
article_metadata: Front Oncol
article_metadata: 2022 Sep 16;12:912490.
article_metadata: immune checkpoint inhibitor (ici) metastatic castration-resistant prostate cancer (mcrpc) microsatellite instability-high (msi-high) neuroendocrine differentiation (ned) pembrolizumab
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/36185251/
article_metadata: Case Reports
article_metadata: PMC9523122
article_metadata: 36185251
article_metadata: Long response duration to pembrolizumab in metastatic, castration-resistant prostate cancer with microsatellite instability-high and neuroendocrine differentiation: A case report
article_metadata: 2022